» Articles » PMID: 30244592

Do Guidelines Provide Evidence-based Guidance to Health Professionals on Promoting Developmentally Appropriate Chronic Condition Self-management in Children? A Systematic Review

Overview
Journal Chronic Illn
Publisher Sage Publications
Specialty General Medicine
Date 2018 Sep 25
PMID 30244592
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To determine whether evidence-based practice guidelines promote developmentally appropriate chronic condition self-management for children with asthma, type 1 diabetes mellitus, and cystic fibrosis.

Methods: Systematic review of clinical guidelines current as at 22 September 2017, including assessment of quality of each guideline using the iCAHE 'Guideline Quality Checklist', and mapping of the supporting evidence.

Results: Fifteen guidelines were identified: asthma (=7) and type 1 diabetes mellitus (=7), CF (=1). Guideline quality was variable, and 11 different grading systems were used. In total, there were 28 recommendations promoting age/developmental considerations. Recommendations focused on: collaboration (=15), chronic condition self-management education (= 17), clinicians' skills (= 4); personalized action plans (=3), problem-solving (=2); and the assessment of children's chronic condition self-management needs (=3). Developmental transitions are highlighted as important time points in some guidelines: preschool (=2), and adolescence (=3). All guidelines encouraged triadic partnerships between children, adult caregivers and clinicians. Evidence supporting the developmental aspects of the guidelines' recommendations was poor; only 14 out of 57 journals listed as evidence were concordant.

Discussion: Current guidelines articulate that developmentally appropriate chronic condition self-management is important; however, more work needs to be done to translate the concept into practical clinical tools.

Citing Articles

Delayed menarche in children and adolescents with type 1 diabetes mellitus: a systematic review and meta-analysis.

Ghitha N, Vathania N, Wiyono L, Pulungan A Clin Pediatr Endocrinol. 2024; 33(3):104-112.

PMID: 38993726 PMC: 11234191. DOI: 10.1297/cpe.2023-0058.


Teplizumab: type 1 diabetes mellitus preventable?.

Misra S, Shukla A Eur J Clin Pharmacol. 2023; 79(5):609-616.

PMID: 37004543 DOI: 10.1007/s00228-023-03474-8.


Supporting the parent-to-child transfer of self-management responsibility for chronic kidney disease: A qualitative study.

Nightingale R, Kirk S, Swallow V, McHugh G Health Expect. 2022; 26(2):683-692.

PMID: 36562551 PMC: 10010075. DOI: 10.1111/hex.13693.


A randomized controlled trial evaluating the effectiveness of a self-management program for adolescents with a chronic condition: a study protocol.

Gauci J, Bloomfield J, Lawn S, Towns S, Hobbs A, Steinbeck K Trials. 2022; 23(1):850.

PMID: 36199075 PMC: 9532816. DOI: 10.1186/s13063-022-06740-9.


Deep Learning for Type 1 Diabetes Mellitus Diagnosis Using Infrared Quantum Cascade Laser Spectroscopy.

Fufurin I, Berezhanskiy P, Golyak I, Anfimov D, Kareva E, Scherbakova A Materials (Basel). 2022; 15(9).

PMID: 35591319 PMC: 9099836. DOI: 10.3390/ma15092984.